Main Theme

HTA beyond 2020: Ready for the New Decade?

One year ahead of the end of a number of prominent HTA strategies and projects, the course will (and has to) be set for future development of HTA worldwide in 2020 and beyond. Thus, the preliminary results will fuel the debate about the future of HTA.

Besides many important strategies and projects dealing with HTA there are some prominent ones like, HTAi’s own strategy paper, accompanied by Horizon 2020, the main research program of the EU Commission, and the EUnetHTA Joint Action 3 project, the proposal of the EU-Commission for a regulation on HTA in Europe after 2020. Moreover, other key scientific programs like IC-Permed, the international consortium for personalized medicine, will be more important than ever. The discussion about subsequent strategies, projects, developments and changes as a result of these projects will be starting in 2019.

Therefore, the HTAi Annual Meeting provides an ideal presentation and discussion platform for opportunities, emerging challenges and possible threats. Trends for harmonization and standardization are confronted by progressive digitalization, disruptive innovations, and the questioning of established evidence requirements. The European proposal for “HTA after 2020” might stand exemplarily for the important international strategic efforts to strengthen HTA for the new decade. Furthermore, globalization takes place and HTA becomes much more important for emerging markets. 2019 is the perfect time to tie this “varicolored bouquet” of important HTA developments together, looking into the future and asking: HTA beyond 2020: Ready for a New Decade?